GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $419K invested in Galmed Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$74.5K
2
+$17.8K
3
+$152

Top Sellers

1
-$58.9K
2
-$17.4K
3
-$13K
4
WWM
Western Wealth Management
Colorado
-$12.6K
5
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$261K
2
$74.5K
3
$43.4K
4
$37.4K
5
$1K
6
$610
7
$499
8
$152
9
$102
10
$51
11
$21
12
$3
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–